BridgeBio Pharma LLC 13D and 13G filings for BridgeBio Oncology Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-18 5:41 pm Purchase | 2025-08-11 | 13D | BridgeBio Oncology Therapeutics Inc. BBOT | BridgeBio Pharma LLC | 13,878,554 17.500% | 13,878,554 (New Position) | Filing |